Code intelligence

C81.10 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code C81.10.

Elevated code riskView ICD-10 detail

Signal breakdown

2 shown · 2 total in platform

Risk: Elevated
0

Critical

0%

1

High

50%

1

Routine

50%

0

Low

0%

New this month

alerts added in last 30 days

Effective soon

no upcoming deadlines

LCD L36335: MolDX: NRAS Genetic Testing — Noridian

Policy LCD-L36335 · Oncology

High

Prepare for NRAS Genetic Testing billing changes in 2026.

LCD L38822: MolDX: Minimal Residual Disease Testing for Cancer — CGS

Policy LCD-L38822 · Oncology

Routine

Prepare for new billing guidelines in oncology testing.

Audit documentation

Building an audit file that includes C81.10?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription